United States · 
What does DAFNA Capital Management, LLC invest in?
DAFNA Capital Management, LLC invests most often at Venture and Growth (100% of the rounds on record), in sectors such as Biotechnology and Medical Devices.
DAFNA Capital Management, LLC highlights
- 01
5 rounds on record
- 02
Mostly Venture and Growth: 100% of its rounds
- 03
1 exits from the portfolio
What they do
DAFNA Capital Management, LLC, a Los Angeles based SEC registered investment advisor, specializes in managing long/short portfolios of predominantly publicly traded biotechnology and medical device companies.From their own website
- Type
- Wealth manager
- Cheque size
- Not stated
- Sectors
- BiotechnologyMedical Devices
- Based in
- Los Angeles, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first5 appearances
- 2015
1 round
- Mar
- 2010
4 rounds
- Sept
- Aug
- Jul
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
FFFariba Fischel GhodsianChief Investment OfficeriForm ADV
NFNathan FischelChief Executive OfficeriForm ADV
XLXun LinChief Compliance OfficeriForm ADV
We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$645Massets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Dafna Capital Management, LLC
- SEC number
- CRD 129053
Funds on its Form ADV
6 private funds, $1.3B in gross assets · filed Mar 2024
- DAFNA Lifescience, L.P.Hedge3 investors$469M
- DAFNA Fund, L.P. Series AHedge77 investors$262M
- DAFNA International Fund LTD. Class AHedge45 investors$203M
- DAFNA Lifescience Select, L.P.Hedge3 investors$179M
- DAFNA Fund, L.P. Series CHedge21 investors$142M
- DAFNA International Fund LTD. Class CHedge11 investors$37M
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
OncothyreonListed$10MMay 2013
An exit counts when it came after the firm's first round in the company. From historical deal records.